Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Akouos Inc (AKUS)
Akouos Inc (AKUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 490,879
  • Shares Outstanding, K 36,936
  • Annual Sales, $ 0 K
  • Annual Income, $ -86,670 K
  • 60-Month Beta -0.55
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.71
Trade AKUS with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.62
  • Most Recent Earnings -0.54 on 11/14/22
  • Next Earnings Date 11/11/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 9.00%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.66
  • Number of Estimates 3
  • High Estimate -0.55
  • Low Estimate -0.74
  • Prior Year -0.72
  • Growth Rate Est. (year over year) +8.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.00 +2.23%
on 11/14/22
13.60 -2.28%
on 11/10/22
+0.12 (+0.91%)
since 10/28/22
3-Month
3.07 +333.61%
on 09/08/22
13.60 -2.28%
on 11/10/22
+9.88 (+289.74%)
since 08/30/22
52-Week
2.32 +474.08%
on 05/25/22
13.60 -2.28%
on 11/10/22
+5.56 (+71.93%)
since 11/26/21

Most Recent Stories

More News
Lilly Completes Acquisition of Akouos Expanding Efforts to Help People with Genetic Diseases

/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Akouos, Inc. (NASDAQ: AKUS). The acquisition...

LLY : 598.05 (+1.66%)
AKUS : 13.29 (+1.06%)
Lilly and Akouos Announce Expiration of Akouos Tender Offer

/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Akouos, Inc. (NASDAQ: AKUS) today announced that the tender offer to purchase all of the issued and...

LLY : 598.05 (+1.66%)
AKUS : 13.29 (+1.06%)
SHAREHOLDER ALERT: Weiss Law Reminds LBC, AERC, AKUS, and ABMD Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

LBC : 9.82 (+0.72%)
AERC : 3.40 (+0.59%)
AKUS : 13.29 (+1.06%)
ABMD : 381.02 (+0.06%)
SHAREHOLDER ALERT: Weiss Law Reminds USER, CLR, AKUS, and LFG Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

USER : 7.50 (-0.13%)
CLR : 74.27 (+0.04%)
AKUS : 13.29 (+1.06%)
LFG : 26.00 (unch)
BP : 35.30 (+1.76%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AKUS, PEBO, LMST, AIMC

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AKUS : 13.29 (+1.06%)
PEBO : 30.85 (+0.33%)
LMST : 23.42 (-1.39%)
AIMC : 61.98 (-0.02%)
SHAREHOLDER ALERT: Weiss Law Reminds RCOR, BTRS, AERC, and AKUS Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

RCOR : 3.20 (+4.92%)
BTRS : 9.49 (-0.11%)
AERC : 3.40 (+0.59%)
AKUS : 13.29 (+1.06%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AKUS, LMST, USER

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AKUS : 13.29 (+1.06%)
LMST : 23.42 (-1.39%)
USER : 7.50 (-0.13%)
SHAREHOLDER ALERT: Weiss Law Reminds USER, CLR, AKUS, and LFG Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

USER : 7.50 (-0.13%)
CLR : 74.27 (+0.04%)
AKUS : 13.29 (+1.06%)
LFG : 26.00 (unch)
BP : 35.30 (+1.76%)
AKOUOS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akouos, Inc. - AKUS

/PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the...

AKUS : 13.29 (+1.06%)
LLY : 598.05 (+1.66%)
SHAREHOLDER ALERT: Weiss Law Reminds AIMC, USER, CLR, and AKUS Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

AIMC : 61.98 (-0.02%)
USER : 7.50 (-0.13%)
CLR : 74.27 (+0.04%)
AKUS : 13.29 (+1.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Akouos, Inc. is a precision genetic medicine company. It develops gene therapies to restore, improve and preserve physiologic hearing. The Company's product candidate includes AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. Akouos, Inc. is based in Boston,...

See More

Key Turning Points

3rd Resistance Point 13.53
2nd Resistance Point 13.43
1st Resistance Point 13.36
Last Price 13.29
1st Support Level 13.19
2nd Support Level 13.09
3rd Support Level 13.02

See More

52-Week High 13.60
Last Price 13.29
Fibonacci 61.8% 9.29
Fibonacci 50% 7.96
Fibonacci 38.2% 6.63
52-Week Low 2.32

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar